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Background: Chagas disease in the Amazon region is considered an emerging anthropozoonosis with a
predominance of the discrete typing units (DTUs) TcI and TcIV. These DTUs are responsible for cases of acute
disease associated with oral transmission. Chronic disease cases have been detected through serological surveys.
However, the mode of transmission could not be determined, or any association of chronic disease with a specific
T. cruzi DTU’s. The aim of this study was to characterize Trypanosoma cruzi in patients with chronic Chagas disease
in the State of Amazonas, Brazil.
Methods: Blood culture and xenodiagnosis were performed in 36 patients with positive serology for Chagas
disease who participated in a serological survey performed in urban and rural areas of Manaus, Amazonas. DNA
samples were extracted from the feces of triatomines used for xenodiagnosis, and the nontranscribed spacer of
the mini-exon gene and the mitochondrial gene cytochrome oxidase subunit II (COII) were amplified by PCR and
sequenced.
Results: Blood culture and xenodiagnosis were negative in 100% of samples; however, molecular techniques
revealed that in 13 out of 36 (36%) fecal samples from xenodiagnosis, T. cruzi was characterized as the DTU TcI, and
different haplotypes were identified within the same DTU.
Conclusion: The DTU TcI, which is mainly associated with acute cases of Chagas disease in the Amazon region, is
also responsible for chronic infection in patients from a region in the State of Amazonas.Background
Chagas disease (CD) is a complex zoonosis found in South
and Central America and is considered to be one of the
most important neglected diseases. It is estimated that
between 8 and 11 million people are infected and that
over 25 million are at risk of developing the disease [1]. In
Brazil, the epidemiological patterns of the disease have
changed as a result of control activities and environ-
mental, economic, and social changes. In the Amazon
region, infection with Trypanosoma cruzi was previously
thought to be an enzootic disease of wild animals [2].* Correspondence: HSilveira@ihmt.unl.pt
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unless otherwise stated.However, in recent years, it has been recognized as an
important emerging anthropozoonosis, with reports of
acute and chronic [3-7] cases and unclear mechanisms
of transmission.
The etiologic agent of CD is the flagellate protozoan
T. cruzi, which is primarily transmitted through the
feces of infected triatomines, may also be transmitted by
blood transfusion, transplacental route, organ transplan-
tation, laboratory accidents and orally through conta-
minated food [8]. This parasite presents high genetic
variability and is divided in 6 specific discrete typing
units (DTUs), termed TcI to TcVI [9,10]. Understanding
the genetics and diversity of the parasite will provide
information about its evolution, biological behavior, and
epidemiological patterns; the natural history of infection;l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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disease [10,11].
In the Brazilian Amazon, Venezuela, Colombia, Central
America, and North America, TcI is the prevailing DTU
and is responsible for most cases of acute and chronic
cardiac CD, whereas TcIV causes sporadic cases of acute
CD in the Amazon [6]. In recent years, the number
of chronic CD cases detected at the Tropical Medicine
Foundation (Fundação de Medicina Tropical) outpatient
clinics has increased [4,5,12].
Previous serological surveys revealed that prevalence
of T. cruzi chronic infection in the municipalities of
Coari and Tefé and also in Manaus rural areas is 0.5%,
1.9% and 1.2%, respectively [13]. Furthermore, [14] re-
gistered a 13% prevalence in the Rio Negro microregion.
Comparing the range of prevalence in both studies, our
study area can be considered of low endemicity.
Understanding the emergence and expansion of CD
in the Amazon requires knowledge of the diversity of
T. cruzi circulating in the region. Thus, the aim of this
study was to characterize T. cruzi DTUs in patients with
chronic infection in the State of Amazonas, Brazil.
Methods
Ethical issues
This project was approved by the ethics committee on hu-
man research of the Dr. Heitor Vieira Dourado TropicalFigure 1 Map of Manaus highlighting the study areas (A: urban area,Medicine Foundation (Fundação de Medicina Tropical
Dr. Heitor Vieira Dourado) (Approval No. 1986). Patients
diagnosed with CD were referred for clinical follow-up as
recommended by the Brazilian Ministry of Health. All
participants involved in the study voluntarily signed an
informed consent form.
Study area
The study was performed in rural and urban areas in the
west side of the city of Manaus, State of Amazonas (AM),
Brazil, where autochthonous acute and chronic cases of
CD [13] and the presence of infected vectors and reser-
voirs of T. cruzi [15] were reported. The area as the whole
Amazon state is considered a low endemicity area for
Chagas disease [3,13]. In the rural area, data collection was
performed in the Tarumã Mirim settlement, which is lo-
cated on federal highway BR 174. In the urban area, the
study was performed in the Tarumã neighbourhood, which
is partly located within an area of environmental protec-
tion and partly within an area of real estate expansion,
which has caused environmental degradation (Figure 1).
Study population
Patients included in this study were identified during a
serological survey performed from October 2010 to July
2012. Of the 1837 participants evaluated during the
survey, 44 were positive by at least two of the threeB: rural area) and the location of participants (red dots).
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assay (ELISA) (Wama® and Bioeasy®), indirect immunofluo-
rescence (IIF) (Wama), and Western Blot (BioMérieux®). Of
these 44 patients, 36 underwent clinical follow-up at the
Dr. Heitor Viera Dourado Tropical Medicine Foundation,
and whole blood culture, xenodiagnosis, and molecular
techniques for the detection of T. cruzi in the feces of
triatomine bugs used for xenodiagnosis were performed.
Whole blood culture
Eight ml of blood were collected in heparinized tubes
from patients who agreed to participate, for each patient,
100ul whole blood was distributed into 2,5 ml of NNN
culture media containing rabbit blood and 40 mg/ml of
gentamycin sulphate. Triplicates were made for each pa-
tient. The search for flagellate forms was performed for a
period of 120 days by inverted optical microscopy [16,17].
Xenodiagnosis
Xenodiagnosis was carried out using two cages each
containing 20 III- and IV-stage nymphs of Triatoma
infestans reared in the laboratory, that were put in con-
tact with the patient’s arm for 30–40 min [18,19]. After
the blood meal, triatomines were maintained at 27°C
and after 30, 60, 90, 120, and 180 days of incubation, the
feces of each insect were analyzed microscopically and
harvested for molecular characterization. Feces of the
40 nymphs used for each patient were collected in pools
of 10 nymphs, at each of the five time points after the
blood meal, totaling 1440 pools. Although Triatominae
species susceptibility for different strains of T. cruzi, on
xenodiagnosis, may differ [20], T. infestans had a better
performance on natural xenodiagnosis and is normally
refractory to T. cruzi [21,22].
DNA extraction
For DNA extraction, the technique described by Zulantay
and colleagues [23] was used. There were a total of 1440
nymphs (40 nymphs from each of 36 patients). Feces of
triatomines in pools of 10 triatomines of the same patient
and time of collection were placed in 1.5-ml microtubes
with 500 μl of phosphate-buffered saline (PBS) pH 7.2 and
incubated in a water bath for 15 minutes at 98°C. Next,
the samples were centrifuged for 3 minutes at 3500 rpm.
A total of 200 μl of the supernatant was removed and
stored at −20°C; this sample was used for PCR.
DNA amplification of the mini-exon gene
The DNA target of the non-transcribed spacer of the mini-
exon gene was amplified according to the multiplex proto-
col previously described by Fernandes and colleagues [24].
The amplification process was performed with an initial
denaturation cycle of 95°C for 5 minutes; 35 cycles of: de-
naturation at 94°C for 30 seconds, annealing at 55°C for30 seconds, and extension at 72°C for 30 seconds; and a
final 10 minute extension at 72°C. The amplified products
were analyzed by electrophoresis on a 2% agarose gel
stained with ethidium bromide. The 150 bp product is
characteristic of T. cruzi zymodeme (Z3) of DTUs TcIII or
TcIV, 100 bp is characteristic of T. rangeli, 200 bp cor-
responds to T. cruzi TcI, and 250 bp is characteristic of
T. cruzi TcII.
Analysis of polymorphisms of the gene encoding
cytochrome oxidase subunit II (COII)
All samples were subjected to mitochondrial DNA
typing by analyzing polymorphisms in the COII gene.
Amplifications were performed with the primers TcMit
31 and TcMit 40, which were designed to amplify a
product of approximately 400 bp [25]. For each PCR re-
action, 2 μl of the sample was used under the following
amplification conditions: an initial denaturation cycle at
94°C for 5 min, followed by 35 cycles of 30 seconds at
94°C, 2 minutes at 48°C, and 2 minutes at 72°C, with a
final extension at 72°C for 5 minutes. Positive and nega-
tive controls were included in each reaction. PCR pro-
ducts were visualized on a 1.5% agarose gel stained with
ethidium bromide.
The amplified PCR products were purified using the
Wizard SV Gel and PCR Clean-up System kit (Promega)
and sequenced in both directions using the primers
TcMit31 and TcMit40. The sequencing reactions were
performed using 1–3 μl of the PCR product, 0.33 pmol of
primer, 2.0 μl of 5× buffer, 1.0 μl of Big Dye Terminator
v.3.1 CycleSequencing Kit (Applied Biosystems), and
water to make a final volume of 10 μL. The reactions were
performed in a Mastercycler Gradient thermocycler
(Eppendorf). PCR products were purified using the
Wizard SV Gel and PCR Clean-up System kit (Promega)
according to the manufacturer’s recommendations. DNA
sequencing was performed on a DNA Analyzer ABI
3130XL (Applied Biosystems). Nucleotide sequences were
edited with the program BioEdit version 7.0.5.2. [26].
Validation of sequence quality was performed, and the
consensus sequence of the sense and antisense strands
was mounted and aligned with standard sequences ob-
tained from GenBank (http://www.ncbi.nlm.nih.gov/). Ge-
nerated sequences were deposited at Genbank [Genbank:
KJ636060 to Genbank:KJ636072]. The following standard
strains were used: TcI (Silvio ×10 cl4), TcII (Esmeraldo
cl3), TcIII (M6241 cl6), TcIV (CANIII cl1), TcV (Mn cl2),
and TcVI (CL Brener), with the respective accession num-
bers [GenBank: EU302222.1, AF359035.1, AF359032.1,
AF359030.1, DQ343718.1, and DQ343645.1].
Phylogenetic trees were constructed using the neighbor-
joining method included in the program MEGA 5.2
[27]. The bootstrap analysis was inferred based on 1500
replicates.
Table 2 Results of PCR of samples from reactive patients
for CD serology






ELISA + IIF 26 (72%) 1 9
ELISA +WB 2 (6%) 0 0
ELISA + IIF +WB 8 (22%) 2 4
Total 36 (100%) 3 13
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Thirty-six patients were included in the study: 21 (58%)
were from a rural area while 15 were from a periurban area;
28 (78%) were originally from the State of Amazonas; 18
(50%) were male and 18 (50%) worked in agriculture.
Patient age ranged between 8 and 73 years, with the highest
percentage (36%) of patients aged more than 50 years
(Table 1). Out of the 36 patients, 26 (72%) were reactive
by ELISA + IIF, two (6%) by ELISA +Western Blot, and 8
(22%) by the three tests (ELISA + IIF +Western Blot;
Table 2).
Blood culture and xenodiagnosis
There was no growth of T. cruzi in blood cultures,
which may be a consequence of standard protocol used
in the laboratory that uses a low amount of patient’s
blood to start hemocultures, while other protocols use
higher amounts of patient’s blood [20]. No flagellated
forms were observed in the fresh triatomine stools.
DNA amplification of the mini-exon gene
T. cruzi positivity was observed in PCR of the mini-exon
gene of triatomine samples after 180 days of xenodiag-
nosis of three (8.3%) patients, with the profile of ampli-
fied products compatible with TcI (Table 2).
Analysis of the mitochondrial gene COII
PCR of the gene encoding COII showed a band of 420 bp
amplified in 13 (36%) samples corresponding to the 13
patients already detected by Mini-exon gene amplification
(Table 2). Sequencing and phylogenetic analysis of theTable 1 Number of patients included in the study by
gender according to area of residence, age, and origin
Variables Female Male Total
Area
Rural 10 (28%) 11 (19%) 21 (58%)
Periurban 8 (22%) 7 (19%) 15 (42%)
Origin (by state)
Amazonas 18 (50%) 10 (28%) 28 (78%)
Pará 2 (6%) 2 (6%)
Ceará 3 (8%) 3 (8%)
Maranhão 1 (3%) 1 (3%)
Piauí 1 (3%) 1 (3%)
Minas Gerais 1 (3%) 1 (3%)
Age group
8 to 20 2 (6%) 2 (6%) 4 (11%)
21 to 30 4 (11%) 0 4 (11%)
31 to 40 4 (11%) 5 (14%) 9 (25%)
41 to 50 4 (11%) 2 (6%) 6 (17%)
> 50 4 (11%) 9 (25%) 13 (36%)gene encoding the COII reference strain Silvio 10× showed
that chronic infection of these patients was caused by the
T. cruzi DTU TcI (Figure 2).
Haplotypes
The analysis revealed the presence of four different hap-
lotypes in the samples. Based on these sequences, haplo-
type TcI COII 1 [6] was the most frequent, occurring in
samples of 9 patients (HUM01,02,03,05,06,07,09,10,12).
The remaining sequences from the samples of four
patients (HUM04 and HUM08, HUM11, and HUM13)
were not previously described (Figure 3).
Of the 13 patients positive for TcI, 8 were male, their
age ranged from 9 to 73 years, 9 were originally from
Amazonas and live in a rural area with eating habits in-
cluding the consumption of wild animal meat and palm
tree fruit juice, 3 had never heard of the disease. Electro-
cardiogram and echocardiogram of seropositive patients
show mild left ventricular diastolic dysfunction in only 2
patients. No digestive system complaints were reported.
Discussion
This study revealed that the DTU TcI causes chronic
CD in an asymptomatic group of patients in the Amazon
region. This study is the first in the region to cha-
racterize TcI in patients with chronic infection, showing
the insertion of man into the sylvatic cycle of T. cruzi
and reinforcing the idea that the Amazon is an emerging
area for CD [14].
TcI has a wide distribution from North America to
South America. In countries of Northern South America
such as Venezuela and Colombia, TcI has been reported
as the predominant lineage and, association with Chagas
disease pathology has been reported [28-30]. TcI has
also been sporadically reported from chagasic patients
throughout the southern cone. Research performed in
the State of Amazonas, especially in the microregion of
Rio Negro, show a disproportionate relationship between
the numbers of individuals with positive anti-T. cruzi
serology and overt clinical cases of CD, with a prevalent
profile of low morbidity and mortality [3,18,31]. In this
region, there are reports of seropositive patients exhi-
biting cardiac abnormalities with no record of digestive
disorders [32].
Figure 2 Phylogenetic tree showing the distribution of Trypanosoma cruzi isolates in rural and periurban areas of Manaus, State
of Amazonas, Brazil, based on the sequencing of the gene encoding cytochrome oxidase subunit II. The following standard strains
obtained from GenBank (DTU (strain name – access number)) were used: TcI (Silvio ×10 cl4 – EU302222.1), TcII (Esmeraldo cl3 – AF359035.1),
TcIII (M6241 cl6 – AF359032.1), TcIV (CANIII cl1 – AF359030.1), TcV (Mn cl2 – DQ343718.1), and TcVI (CL Brener – DQ343645.1). TcCOII1, haplotype
described in (6).
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reveal that TcI shows lower parasitemia compared with
the DTUs TcV and TcVI [33]. Considering that the bio-
logical characteristics of the different DTUs play an im-
portant role in the prevalence of latent chronic Chagas
infection and the low immune power of circulatingFigure 3 Representation of Trypanosoma cruzi haplotypes identified a
subunit II gene. Standard strains obtained from GenBank [DTU (strain nam
cl3 -AF359035.1), TcIII (M6241 cl6- AF359032.1), TcIV (CANIII cl1 -AF359030.1
haplotype described in (6).T. cruzi, it has been hypothesized that the T. cruzi strains
circulating in the State of Amazonas have low virulence
and pathogenicity [34].
Nine out of the 13 patients characterized as DTU TcI
had a common haplotype, which was also the most fre-
quent in outbreaks reported in the Amazon by Monteiros DTU TcI identified by sequencing of the cytochrome oxidase
e – access number)]: TcI (Silvio ×10 cl4- EU302222.1), TcII (Esmeraldo
), TcV (Mn cl2- DQ343718.1), and TcVI (CL Brener- DQ343645.1). TcCOII1,
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Amazon region, and 4 were originally from northeastern
and midwestern regions of Brasil. The T. cruzi haplo-
types isolated from these four patients fall into the most
prevalent haplotype in the region present in the study, sug-
gesting that they acquired the infection locally, progressing
to the chronic phase.
An important biological factor in the natural history
and epidemiology of CD is the high diversity of vectors
and wild animal reservoirs of T. cruzi, resulting in an
intense and complex sylvatic transmission cycle. This
factor may be related to parasite genetic diversity. The
same study by Monteiro et al. [6] revealed four haplotypes
of DTUs TcI and TcIV causing infections; however, no
correlation between haplotype and clinical and epidemio-
logical factors of CD or the interaction of the parasite with
the vector were observed [6]. Genetic variability within
TcI has been highlighted by other studies and associated
with severe forms of CD in Colombia and Argentina
[30,35,36]. In Venezuela, as well as other Northern South
Americas, there are a number of reports showing gene-
tically homogeneous TcI strains from humans, when
compared with sylvatic TcI strains, from the same areas
[30,37,38].
Although the present study did not find any association
between haplotype and symptoms suggestive of CD, it is
unclear whether the different clinical forms of CD may be
associated with a specific T. cruzi DTU, clone, transmis-
sion mode or host genetics [6]. Gaining knowledge about
the biological properties of the TcI lineage, which certainly
plays an important role in the CD pathogenesis and
response to the specific chemotherapy in the Amazon
region, represents a challenge for future research [39-41].
Intensive programs of vector control and transfusion sur-
veillance in long-established endemic areas of Brazil have
been successful; however, CD has been rising in the Ama-
zon region in the form of outbreaks associated with oral
transmission. CD is thus considered as neglected and
emerging, as evidenced by the occurrence of acute and
chronic cases that indicate a new epidemiological profile of
the disease. Thus, the importance of performing serological
surveys in the region needs to be emphasized due to the
cases diagnosed in the present study. Moreover, in addition
to the planning and implementation of disease control
measures, complementary PCR as a tool for DTU classifi-
cation should also be highlighted, due to limited data on
the relationship between the specific DTU genotypes/
haplotypes types and clinic-epidemiological features of CD.
Conclusions
In this study, T. cruzi infection was confirmed in 36
patients with reactive serology for chronic CD, parasites
were detected using molecular parasitological techniques
and genotyped in 13 of these patients. Furthermore,T. cruzi DNA was found in triatomines used for xenodiag-
nosis of patients with positive serology for chronic CD,
being DTU TcI the detected strain.
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